Trial Registration Section
CONSORT 2025 asks randomized-trial reports to provide trial-registration information, including the registry, identifying number or URL, and registration date, supporting traceability to the registered record. Not every study is a registrable clinical or randomized trial, and requirements vary by jurisdiction and venue. Do not create registration details when the study was not registered; report the actual status under the applicable rules.
A Trial Registration section or statement identifies the applicable trial registry and registration record so readers can connect the report to its registered protocol information.
Key details
Important caveats
Scope Boundary
Not every study is a registrable clinical or randomized trial, and requirements vary by jurisdiction and venue. Do not create registration details when the study was not registered; report the actual status under the applicable rules.
Further guidance
Content
For a registered randomized trial, report the registry name, identifying number or link, and registration timing or date as required by the applicable reporting standard, journal, funder, or law.
Purpose
A Trial Registration section or statement identifies the applicable trial registry and registration record so readers can connect the report to its registered protocol information.
Sources and evidence
Sources are shown with the role they play in this guide. Historical or style-sensitive claims are kept within the evidence boundary described above.
- CONSORT 2025 statement: updated guideline for reporting randomised trials (opens in a new tab)BMJ / CONSORT Group · Primary 2025 CONSORT reporting guideline for randomized trials, including participant flow and trial-registration information.